EP1158299A4 - Dosage de composant d'un echantillon biologique - Google Patents

Dosage de composant d'un echantillon biologique

Info

Publication number
EP1158299A4
EP1158299A4 EP00905409A EP00905409A EP1158299A4 EP 1158299 A4 EP1158299 A4 EP 1158299A4 EP 00905409 A EP00905409 A EP 00905409A EP 00905409 A EP00905409 A EP 00905409A EP 1158299 A4 EP1158299 A4 EP 1158299A4
Authority
EP
European Patent Office
Prior art keywords
component
biological sample
density lipoprotein
assaying
sample component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP00905409A
Other languages
German (de)
English (en)
Other versions
EP1158299A1 (fr
EP1158299B1 (fr
Inventor
Koji Kishi
Tsutomu Kakuyama
Koji Ochiai
Yuzo Hasegawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sysmex Corp
Original Assignee
International Reagents Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Reagents Corp filed Critical International Reagents Corp
Publication of EP1158299A1 publication Critical patent/EP1158299A1/fr
Publication of EP1158299A4 publication Critical patent/EP1158299A4/fr
Application granted granted Critical
Publication of EP1158299B1 publication Critical patent/EP1158299B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
EP00905409A 1999-03-01 2000-02-29 Dosage de composant d'un echantillon biologique Expired - Lifetime EP1158299B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5333099 1999-03-01
JP5333099 1999-03-01
PCT/JP2000/001172 WO2000052480A1 (fr) 1999-03-01 2000-02-29 Dosage de composant d'un echantillon biologique

Publications (3)

Publication Number Publication Date
EP1158299A1 EP1158299A1 (fr) 2001-11-28
EP1158299A4 true EP1158299A4 (fr) 2002-08-14
EP1158299B1 EP1158299B1 (fr) 2008-07-09

Family

ID=12939734

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00905409A Expired - Lifetime EP1158299B1 (fr) 1999-03-01 2000-02-29 Dosage de composant d'un echantillon biologique

Country Status (8)

Country Link
US (1) US7208287B2 (fr)
EP (1) EP1158299B1 (fr)
JP (1) JP4547095B2 (fr)
KR (1) KR100682082B1 (fr)
AT (1) ATE400816T1 (fr)
CA (1) CA2363570A1 (fr)
DE (1) DE60039418D1 (fr)
WO (1) WO2000052480A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE449867T1 (de) 2002-10-16 2009-12-15 Kyowa Medex Co Ltd Verfahren und reagens zur messung von cholesterin in lipoproteinen hoher dichte
JPWO2004035817A1 (ja) * 2002-10-16 2006-02-16 協和メデックス株式会社 高密度リポ蛋白中のコレステロールの測定方法および試薬
JPWO2004048605A1 (ja) * 2002-11-27 2006-03-23 第一化学薬品株式会社 特定リポ蛋白中の脂質測定法
JP4796489B2 (ja) * 2004-04-15 2011-10-19 協和メデックス株式会社 高密度リポ蛋白中のコレステロールの測定方法
TWI372783B (en) * 2005-04-27 2012-09-21 Kyowa Medex Co Ltd A process for measuring the cholesterol in high density lipoprotein
GB0609493D0 (en) * 2006-05-12 2006-06-21 Oxford Biosensors Ltd Cholesterol sensor
GB0609494D0 (en) * 2006-05-12 2006-06-21 Oxford Biosensors Ltd HDL cholesterol sensor using specific surfactant
WO2010148130A1 (fr) * 2009-06-17 2010-12-23 Maine Standards Company, Llc Procédé de mesure d'apolipoprotéines spécifiques à la lipoprotéine
EP2562251B1 (fr) * 2011-08-25 2016-08-17 Roche Diagnostics GmbH Oxydase de cholestérol
KR102381248B1 (ko) 2011-11-11 2022-04-01 엑시스-시일드 에이에스 혈액 샘플 분석 방법
US10077286B2 (en) 2012-04-20 2018-09-18 Denka Seiken Co., Ltd. Method for removal of triglycerides in lipoproteins other than low-density lipoproteins
WO2014034823A1 (fr) 2012-08-31 2014-03-06 協和メデックス株式会社 Procédé de dosage du cholestérol présent dans les lipoprotéines de haute densité
CN114774513B (zh) * 2022-05-20 2023-05-12 浙江伊利康生物技术有限公司 一种小而密低密度脂蛋白胆固醇的测定试剂及测试方法
CN114891854B (zh) * 2022-05-20 2023-05-30 浙江伊利康生物技术有限公司 一种用于测定小而密低密度脂蛋白胆固醇的试剂及其试剂盒

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892816A (en) * 1984-10-31 1990-01-09 Amano Pharmaceutical Co., Ltd. Method for the determination of cholesterol
WO1997045553A1 (fr) * 1996-05-29 1997-12-04 Daiichi Pure Chemicals Co., Ltd. Procede de determination quantitative des cholesterols des lipoproteines de basse densite
US5814472A (en) * 1997-05-13 1998-09-29 Wako Pure Chemical Industries, Ltd. Measurement of LDL-cholesterol
EP0887422A1 (fr) * 1996-12-09 1998-12-30 DENKA SEIKEN Co., Ltd. Procede pour determiner la teneur en cholesterol des lipoproteines de haute densite
WO1998059068A1 (fr) * 1997-06-25 1998-12-30 International Reagents Corporation Procede servant a analyser des specimens biologiques afin de rechercher des substances contenues dans leurs constituants et reactif utilise dans ce procede

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636851A1 (de) 1986-10-29 1988-05-11 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung des cholesterins der hdl-fraktion
US5185247A (en) * 1989-03-10 1993-02-09 Miles Inc. Stabilization of oxidase enzyme-based test strips
JP2994831B2 (ja) * 1991-12-27 1999-12-27 国際試薬株式会社 コレステロールの定量法および定量用試薬
US5460974A (en) * 1992-10-13 1995-10-24 Miles Inc. Method of assaying whole blood for HDL cholesterol
JP3614514B2 (ja) * 1995-06-21 2005-01-26 国際試薬株式会社 高比重リポ蛋白分画中のコレステロールの定量方法及び定量用試薬キット
JPH09285298A (ja) * 1996-04-22 1997-11-04 Iatron Lab Inc Ｈｄｌ−コレステロールの測定方法及び測定用試薬
JPH1084997A (ja) * 1996-07-25 1998-04-07 Wako Pure Chem Ind Ltd Ｌｄｌ−コレステロールの測定法
JPH1130617A (ja) * 1997-05-13 1999-02-02 Wako Pure Chem Ind Ltd Ｌｄｌ−コレステロール測定法
JPH10311833A (ja) * 1997-05-13 1998-11-24 Wako Pure Chem Ind Ltd Ｌｄｌ−コレステロールの測定方法
US6114134A (en) * 1997-06-25 2000-09-05 International Reagents Corporation Method for assaying biological specimens for substances contained in the components thereof and reagent to be used in this method
JP3981190B2 (ja) * 1997-07-07 2007-09-26 シスメックス株式会社 コレステロールの定量方法及び定量用試薬
JPH1156395A (ja) * 1997-08-27 1999-03-02 Dai Ichi Pure Chem Co Ltd コレステロールの定量法
JP3822340B2 (ja) * 1997-11-26 2006-09-20 シスメックス株式会社 リポ蛋白質コレステロールの定量方法および試薬キット
US5925534A (en) 1998-06-08 1999-07-20 Wako Pure Chemical Industries, Ltd. Method for measuring LDL-cholesterol
JP2000325097A (ja) * 1999-05-21 2000-11-28 Showa Denko Kk リポ蛋白質コレステロールの測定方法及び測定試薬

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4892816A (en) * 1984-10-31 1990-01-09 Amano Pharmaceutical Co., Ltd. Method for the determination of cholesterol
WO1997045553A1 (fr) * 1996-05-29 1997-12-04 Daiichi Pure Chemicals Co., Ltd. Procede de determination quantitative des cholesterols des lipoproteines de basse densite
EP0913484A1 (fr) * 1996-05-29 1999-05-06 Daiichi Pure Chemicals Co., Ltd. Procede de determination quantitative des cholesterols des lipoproteines de basse densite
EP0887422A1 (fr) * 1996-12-09 1998-12-30 DENKA SEIKEN Co., Ltd. Procede pour determiner la teneur en cholesterol des lipoproteines de haute densite
US5814472A (en) * 1997-05-13 1998-09-29 Wako Pure Chemical Industries, Ltd. Measurement of LDL-cholesterol
WO1998059068A1 (fr) * 1997-06-25 1998-12-30 International Reagents Corporation Procede servant a analyser des specimens biologiques afin de rechercher des substances contenues dans leurs constituants et reactif utilise dans ce procede
EP1020532A1 (fr) * 1997-06-25 2000-07-19 International Reagents Corporation Procede servant a analyser des specimens biologiques afin de rechercher des substances contenues dans leurs constituants et reactif utilise dans ce procede

Also Published As

Publication number Publication date
US20040161811A1 (en) 2004-08-19
JP4547095B2 (ja) 2010-09-22
KR100682082B1 (ko) 2007-02-12
EP1158299A1 (fr) 2001-11-28
WO2000052480A1 (fr) 2000-09-08
KR20010103016A (ko) 2001-11-17
DE60039418D1 (de) 2008-08-21
EP1158299B1 (fr) 2008-07-09
CA2363570A1 (fr) 2000-09-08
US7208287B2 (en) 2007-04-24
ATE400816T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
EP1158299A4 (fr) Dosage de composant d'un echantillon biologique
AU2307597A (en) Method for quantitatively determining ldl cholesterols
MX9604514A (es) Metodo para determinar cuantitativamente colesterol.
EP0887422A4 (fr) Procede pour determiner la teneur en cholesterol des lipoproteines de haute densite
BR9305780A (pt) Processo para a determinação de homocisteina em uma amostra e conjunto analitico para uso na determinação de homocisteina em uma amostra
EP1329724A3 (fr) Dispositif et méthode d'essai pour les lipoprotéines à haute densité
WO2008105486A1 (fr) Réactif pour déterminer la quantité de petite lipoprotéine dense de faible densité
ZA856789B (en) Methods of assay
EP0285439A3 (en) Techniques for preparing specimens for bacterial assays
TW348216B (en) Method for the determination of urinary protein and creatinine
AU3565393A (en) A method for analyzing particle-enhanced agglutination reactions in centrifugal analyzers by determining the brightening of turbidity
MY125519A (en) Pretreatment method of samples for cholesterol quantitation, and quantitation method of cholesterol in specific lipoprotein by the use of the pretreatment method
HK1058397A1 (en) High-density lipoprotein assay device and method
AU2001260714A1 (en) Method of analyzing components in biological samples
EP1164376A4 (fr) Procede de quantification du cholesterol
AU3996693A (en) Process for the immunochemical determination of an analyte
WO2002048398A3 (fr) Systeme d'hybridation in situ de mise en evidence specifique de micro-organismes
AU4462893A (en) Immunochemical method for detecting an analyte

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010827

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020627

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7G 01N 33/92 A, 7C 12Q 1/44 B, 7C 12Q 1/60 B

17Q First examination report despatched

Effective date: 20050421

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SYSMEX CORPORATION

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 60039418

Country of ref document: DE

Date of ref document: 20080821

Kind code of ref document: P

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080709

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20081020

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20081209

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080709

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080709

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080709

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080709

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20090414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080709

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090331

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090228

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20081009

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20081010

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080709

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20140211

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20140226

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20140417

Year of fee payment: 15

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60039418

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20150228

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20151030

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150228

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150901

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150302